• Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
Close Search
00
GBAF LogoGBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
GBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Wealth
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2024 GBAF Publications Ltd - All Rights Reserved.

    ;
    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Headlines

    Posted By Global Banking and Finance Review

    Posted on April 23, 2025

    Featured image for article about Headlines

    (Reuters) -The Slovak government halted purchases of COVID-19 vaccines on Wednesday pending a review of their safety by the Slovak Academy of Sciences, Prime Minister Robert Fico said.

    Fico, a populist who has himself declined coronavirus vaccination, has long criticised the COVID policies of the previous governments, including vaccination campaigns before his return to power in 2023.

    Fico told a televised briefing that based on a 2023 agreement signed by a previous administration, Slovakia was still due to receive 300,000 more vaccine doses for around 5.7 million euros ($6.48 million). He did not name the suppliers.

    "We have an expert opinion from a registered expert that the vaccines used in Slovakia contained enormously high levels of DNA and substances which the producer did not show in the packaging material," Fico told a news conference.

    "Therefore the decision to not take or pay temporarily (for the remaining vaccines) until we have more information is right," he said.

    The cabinet's decision to pause vaccine purchases followed a recommendation by vaccine opponent Peter Kotlar, the government's envoy in charge of reviewing pandemic policies.

    Kotlar has claimed, without evidence, that vaccines based on mRNA technology were not safe and called on the government to stop inoculations.

    Producers of mRNA vaccines Moderna and Pfizer did not immediately respond to a request for comment.

    Slovak drug regulator SUKL last month sharply criticised Kotlar's views, saying they were unscientific and dangerous, and said it was considering filing a criminal complaint for spreading panic.

    The main Slovak opposition party, Progressive Slovakia, said Fico was using Kotlar's "conspiratory delusions" to distract attention from his government's policy failures.

    Fico has repeatedly doubted the benefits of COVID-19 vaccinations, and organised a protest that went against lockdown rules during the pandemic.

    ($1 = 0.8794 euros)

    (Reporting by Jan Lopatka and Jason Hovet in PragueEditing by Bill Berkrot)

    Recommended for you

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe